Stay updated on Ixazomib Combo in Relapsed Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the Ixazomib Combo in Relapsed Multiple Myeloma Clinical Trial page.

Latest updates to the Ixazomib Combo in Relapsed Multiple Myeloma Clinical Trial page
- Check6 days agoChange DetectedThe history now includes the addition of Revision: v3.5.2 and the deletion of Revision: v3.5.0.SummaryDifference0.1%

- Check13 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check28 days agoChange DetectedRevision history updated with a new entry for v3.5.0 and the v3.4.3 entry removed.SummaryDifference0.1%

- Check42 days agoChange DetectedThe history page now displays Revision: v3.4.3, replacing the previous Revision: v3.4.2.SummaryDifference0.1%

- Check70 days agoChange DetectedA new revision entry (v3.4.2) was added to the history, and an operating-status notice and an older revision (v3.4.1) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check78 days agoChange DetectedA site-wide funding notice was added and the page revision tag updated to v3.4.1, while the previous revision v3.4.0 was removed. These changes do not modify the study record content or data; To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.7%

- Check85 days agoChange DetectedThe history page now includes a glossary toggle and color-code legend (green for additions, red for deletions). It also shows the new revision note Revision: v3.4.0 and removes No FEAR Act data and Revision: v3.3.4.SummaryDifference0.9%

Stay in the know with updates to Ixazomib Combo in Relapsed Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Ixazomib Combo in Relapsed Multiple Myeloma Clinical Trial page.